GET THE APP

Inner Banner image

Call for Abstract

Date

July 19-20, 2021 at 10:00 AM JST 
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Location

Osaka, Japan

Clinical trials for the possibilities of new remedies and their most part started and financed by industry. There are various clinical trials initiated by clinical professionals. Clinical research is frequently performed all over the world, which can now and then, be expansive ones. As an outcome, clinical research is exceedingly controlled.

Pre-clinical research is a stage of research that begins before clinical trials and during which important feasibility, iterative testing and drug safety data are collected, typically in laboratory animals. The main goals of pre-clinical research are to determine a starting, safe dose for first-in-human study and assess for the potential toxicity of the product, which typically include new medical devices, prescription drugs, and diagnostics.

Clinical Trials for different diseases leads to assessing at least one medication for treating a disorder or a condition. Discovering approaches to keep the underlying advancement or continuous ailments or conditions. These can incorporate immunizations or way of changes among various aspects.

Clinical study design is the formation of trials, experiments, and observational studies in medical, clinical and epidemiological. The goal of a clinical study is to assess the safety, efficacy, and the mechanism of action of an investigational medicinal procedure. It can also be to investigate a drug, device or procedure that has already been approved but is still in need of further investigation, typically with respect to long-term effects or cost-effectiveness.

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. A variety of approaches is employed to identify chemical compounds that may be developed and marketed. Discovering drugs may be a commercial success, or a public health success, involves a complex interaction between investors, industry, academia, patent laws, regulatory exclusivity and marketing. Meanwhile, for disorders whose rarity means that no large commercial success or public health effect can be expected, the orphan drug funding process ensures that people who experience those disorders can have some hope of pharma therapeutic advances.

Pharmacovigilance is the pharmacological science relates to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. Pharmacovigilance heavily focuses on adverse drug reactions which are defined as any response to a drug which is noxious and unintended including lack of efficacy. Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.

Bioethics is the investigation of the commonly questionable moral issues rising up out of new circumstances and potential outcomes realized by advances in medication. It is additionally moral insight as it identifies with therapeutic approach, practice, and research. One of the principal ranges tends to present day bioethicists were that of human experimentation.

Clinical microbiology research is a discipline that encompasses a broad range of testing methodologies. Although significant improvements in testing methodologies have been made, clinical microbiology remains heavily reliant on culture-based methods and phenotypic methods for identification of culture organisms. Medical microbiology is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health.

Technology plays a critical role in drug development and the R&D value chain by revolutionizing clinical trials and decreasing the failure rate. Though the supply of technology has been increasing and regulation of innovative methods is easing, pharmaceutical companies have been slow to use the emerging technologies, due to the ambiguity prevailing around this space and a highly fragmented supply market. This article outlines the key technologies that have a high impact across trial phases.

Clinical Data Management (CDM) is a critical phase in clinical research, which leads to generation of high-quality, reliable, and statistically sound data from clinical trials. This helps to produce a drastic reduction in time from drug development to marketing. Team members of CDM are actively involved in all stages of clinical trial right from inception to completion. With the implementation of regulatory compliant data management tools, CDM team can meet these demands.

A case report is a detailed report of the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient. Case reports may contain a demographic profile of the patient, but usually describe an unusual or novel occurrence. Some case reports also contain a literature review of other reported cases. Case reports are professional narratives that provide feedback on clinical practice guidelines and offer a framework for early signals of effectiveness, adverse events, and cost. They can be shared for medical, scientific, or educational purposes.

In recent years, clinical trials with stem cells have taken the emerging field in many new directions. While numerous teams continue to refine and expand the role of bone marrow and cord blood stem cells for their vanguard uses in blood and immune disorders, many others are looking to expand the uses of the various types of stem cells found in bone marrow and cord blood, in particular mesenchymal stem cells, to uses beyond those that could be corrected by replacing cells in their own lineage. Early results from these trials have produced mixed results often showing minor or transitory improvements that may be attributed to extracellular factors.

Abstracts enquiry

abstracts@meetingsint.com

Finance enquiry

finance@meetingsint.com

Contact Enquiry

contact@meetingsint.com

Sponsors / Advertising

sponsor@meetingsint.com

Meetings International Pte Ltd, 28 Maxwell Road, 03-05 Red Dot Traffic, Singapore, 069120.